Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation

European Respiratory Journal

Volumn 42, Issue 6, 2013, Pages 1757-1759

  Fukuhara, Atsuro ^a   Tanino, Yoshinori ^a   Ishii, Taeko ^a   Inokoshi, Yayoi ^a   Saito, Kazue ^a   Fukuhara, Naoko ^a   Sato, Suguru ^a   Saito, Junpei ^a   Ishida, Takashi ^a   Yamaguchi, Hiroki ^b   Munakata, Mitsuru ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; LACTATE DEHYDROGENASE;

ADULT; APLASTIC ANEMIA; BRONCHIECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRACKLE; DYSKERATOSIS CONGENITA; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE MUTATION; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; LUNG CYST; LUNG FIBROSIS; MUTATOR GENE; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY FAILURE; SKIN PIGMENTATION; SOUTHERN BLOTTING; SUBCUTANEOUS EMPHYSEMA; TELOMERE; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TINF2 GENE;

ADULT; DNA MUTATIONAL ANALYSIS; DYSKERATOSIS CONGENITA; FATAL OUTCOME; FEMALE; HUMANS; MUTATION; PNEUMOTHORAX; PULMONARY FIBROSIS; STEROIDS; TELOMERE-BINDING PROTEINS;

EID: 84890110189     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00149113     Document Type: Letter

References (10)

1. Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program 2011; 2011: 480-486.
2. Vulliamy TJ, Marrone A, Knight SW, et al. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107: 2680-2685.
3. Walne AJ, Vulliamy T, Beswick R, et al. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood 2008; 112: 3594-3600.
4. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413: 432-435.
5. Marrone A, Sokhal P, Walne A, et al. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica 2007; 92: 1013-1020.
6. Armanios M, Chen JL, Chang YP, et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA 2005; 102: 15960-15964.
7. Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005; 352: 1413-1424.
8. Safa WF, Lestringant GG, Frossard PM. X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax 2001; 56: 891-894.
9. Savage SA, Giri N, Baerlocher GM, et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 2008; 82: 501-509.
10. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100-2110.